Landfar Bio-medicine Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 34.74 million compared to CNY 64.82 million a year ago. Revenue was CNY 34.74 million compared to CNY 64.82 million a year ago.

Net loss was CNY 1.98 million compared to net income of CNY 0.159904 million a year ago. Basic loss per share from continuing operations was CNY 0.0063 compared to basic earnings per share from continuing operations of CNY 0.0005 a year ago. Diluted loss per share from continuing operations was CNY 0.0063 compared to diluted earnings per share from continuing operations of CNY 0.0005 a year ago.